Chargement en cours...
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis
BACKGROUND: Clinicians caring for patients with Multiple Sclerosis (MS) need improved biomarkers to aid them in disease management. OBJECTIVE: We assessed the predictive value of the candidate biomarker CXCL13 index in comparison to oligoclonal bands (OCBs) and CSF neurofilament light (NfL) concentr...
Enregistré dans:
| Publié dans: | Mult Scler J Exp Transl Clin |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747124/ https://ncbi.nlm.nih.gov/pubmed/33403120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320981396 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|